45. Pennanen L, Gotz J (2005) Different tau epitopes define Abeta42-mediated tau insolubility. Biochem Biophys Res Commun 337: 1097–1101. 46. Doerflinger H, Benton R, Shulman JM, St Johnston D (2003) The role of PAR-1 in regulating the polarised microtubule cytoskeleton in the Drosophila follicular epithelium. Development 130: 3965–3975. 47. Su Y, Ryder J, Li B, Wu X, Fox N, et al. (2004) Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. Biochemistry 43: 6899–6908. 48. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH (1992) Glycogen synthase kinase-3 induces Alzheimer’s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147: 58–62. 49. Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, et al. (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule- associated protein tau. FEBS Lett 314: 315–321. 50. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, et al. (1994) Alzheimer’s disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4: 1077–1086. 51. Brownlees J, Irving NG, Brion JP, Gibb BJ, Wagner U, et al. (1997) Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes. Neuroreport 8: 3251–3255. 52. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, et al. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegener- ation in GSK-3beta conditional transgenic mice. Embo J 20: 27–39. 53. McGowan E, Eriksen J, Hutton M (2006) A decade of modeling Alzheimer’s disease in transgenic mice. Trends Genet 22: 281–289. 54. Magrane J, Rosen KM, Smith RC, Walsh K, Gouras GK, et al. (2005) Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J Neurosci 25: 10960–10969. 55. Folwell J, Cowan CM, Ubhi KK, Shiabh H, Newman TA, et al. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer’s disease. Exp Neurol 223: 401–409. 56. Joutel A, Tournier-Lasserve E (1998) Notch signalling pathway and human diseases. Semin Cell Dev Biol 9: 619–625. 57. Dierick H, Bejsovec A (1999) Cellular mechanisms of wingless/Wnt signal transduction. Curr Top Dev Biol 43: 153–190. 58. Drewes G, Ebneth A, Preuss U, Mandelkow EM, Mandelkow E (1997) MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89: 297–308. 59. Nishimura I, Yang Y, Lu B (2004) PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 116: 671–682. 60. Iijima K, Gatt A, Iijima-Ando K (2010) Tau Ser262 phosphorylation is critical for A{beta}42-induced tau toxicity in a transgenic Drosophila model of Alzheimer’s disease. Hum Mol Genet. epub ahead of print. 61. Gomez de Barreda E, Perez M, Gomez Ramos P, de Cristobal J, Martin- Maestro P, et al. Tau-knockout mice show reduced GSK-3-induced hippocam- pal degeneration and learning deficits. Neurobiol Dis 37: 622–629. 62. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, et al. (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292: 1550–1552. 63. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, et al. (2003) Insulin- degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 100: 4162–4167. GSK-3 Inhibition Ameliorates Ab Pathology 64. Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, et al. (2003) Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci U S A 100: 6221–6226. 65. Eckman EA, Watson M, Marlow L, Sambamurti K, Eckman CB (2003) Alzheimer’s disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem 278: 2081–2084. 66. Melchor JP, Pawlak R, Strickland S (2003) The tissue plasminogen activator- plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J Neurosci 23: 8867–8871. 67. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, et al. (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40: 1087–1093. 68. Ho L, Qin W, Pompl PN, Xiang Z, Wang J, et al. (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. Faseb J 18: 902–904. 69. Killick R, Scales G, Leroy K, Causevic M, Hooper C, et al. (2009) Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice. Biochem Biophys Res Commun 386: 257–262. 70. Iijima-Ando K, Hearn SA, Granger L, Shenton C, Gatt A, et al. (2008) Overexpression of neprilysin reduces alzheimer amyloid-beta42 (Abeta42)- induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age- dependent axon pathology, and premature death in Drosophila. J Biol Chem 283: 19066–19076. 71. Tsuda M, Kobayashi T, Matsuo T, Aigaki T Insulin-degrading enzyme antagonizes insulin-dependent tissue growth and Abeta-induced neurotoxicity in Drosophila. FEBS Lett. 72. He B, Meng YH, Mivechi NF (1998) Glycogen synthase kinase 3beta and extracellular signal-regulated kinase inactivate heat shock transcription factor 1 by facilitating the disappearance of transcriptionally active granules after heat shock. Mol Cell Biol 18: 6624–6633. 73. Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A (2006) Opposing activities protect against age-onset proteotoxicity. Science 313: 1604–1610. 74. Allen MJ, Godenschwege TA, Tanouye MA, Phelan P (2006) Making an escape: development and function of the Drosophila giant fibre system. Semin Cell Dev Biol 17: 31–41. 75. Rival T, Soustelle L, Strambi C, Besson MT, Iche M, et al. (2004) Decreasing glutamate buffering capacity triggers oxidative stress and neuropil degeneration in the Drosophila brain. Curr Biol 14: 599–605. 76. Ganetzky B, Flanagan JR (1978) On the relationship between senescence and age-related changes in two wild-type strains of Drosophila melanogaster. Exp Gerontol 13: 189–196. 77. Allen MJ, Shan X, Caruccio P, Froggett SJ, Moffat KG, et al. (1999) Targeted expression of truncated glued disrupts giant fiber synapse formation in Drosophila. J Neurosci 19: 9374–9384. 78. Tanouye MA, Wyman RJ (1980) Motor outputs of giant nerve fiber in Drosophila. J Neurophysiol 44: 405–421. 79. Gorczyca M, Hall JC (1984) Identification of a cholinergic synapse in the giant fiber pathway of Drosophila using conditional mutations of acetylcholine synthesis. J Neurogenet 1: 289–313. 80. Burns M, Gaynor K, Olm V, Mercken M, LaFrancois J, et al. (2003) Presenilin redistribution associated with aberrant cholesterol transport enhances beta- amyloid production in vivo. J Neurosci 23: 5645–5649. PLoS Genetics | www.plosgenetics.org 18 September 2010 | Volume 6 | Issue 9 | e1001087